;
Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Thoratec management update

    Thoratec Corp. (NASDAQ:THOR), Pleasanton, Calif. Business: Diagnostic, Cardiovascular Hired: Vasant Padmanabhan as SVP of technical operations, a newly created position, formerly VP of product development for the …

    Published on 10/20/2014
  • Xagenic management update

    Xagenic Inc., Toronto, Ontario Business: Diagnostic Departed: Bruce Cohen as executive chairman Hired: Timothy Still as president, CEO and a director, formerly president and CEO of Accumetrics Inc., which merged with …

    Published on 10/20/2014
  • Agendia management update

    Agendia N.V., Amsterdam, the Netherlands Business: Diagnostic, Microarrays Hired: Jan Egberts, a director, as CEO, formerly CEO of OctoPlus N.V., which Dr. Reddy's Laboratories Ltd. acquired; he succeeds David Macdonald

    Published on 10/13/2014
  • Alexion board of directors update

    Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Cheshire, Conn. Business: Hematology, Neurology, Endocrine/Metabolic Deceased: Max Link, chairman, at the age of 74; he is succeeded by CEO Leonard Bell Transitioned: Douglas …

    Published on 10/13/2014
  • Astellas management update

    Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Pharmaceuticals Promoted: Brian McLellan to president at Astellas' Astellas Pharma Technologies in the Americas region from VP of technology and operations at …

    Published on 10/13/2014
  • Bio-Rad Laboratories management update

    Bio-Rad Laboratories Inc. (NYSE:BIO), Hercules, Calif. Business: Diagnostic, Supply/Service Transitioned: John Goetz to COO from head of the clinical diagnostics group; Shannon Hall to EVP and president of the life …

    Published on 10/13/2014
  • bioMerieux management update

    bioMerieux S.A. (Euronext:BIM), Marcy l'Etoile, France Business: Diagnostic, Pharmacogenetics Hired: Nicolas Barthelemy as president and CEO of bioMerieux's bioTheranostics Inc. subsidiary, formerly chief commercial …

    Published on 10/13/2014
  • BioTime management update

    BioTime Inc. (NYSE-M:BTX), Alameda, Calif. Business: Gene/Cell therapy, Pulmonary, Diagnostic Hired: Rafhael Cedeno as chief technology officer and head of product at BioTime's LifeMap Solutions Inc. subsidiary, …

    Published on 10/13/2014
  • Celsion board of directors update

    Celsion Corp. (NASDAQ:CLSN), Lawrenceville, N.J. Business: Drug delivery, Cancer Deceased: Max Link, chairman, at the age of 74; he is succeeded by President, CEO and Michael Tardugno, who is also a director

    Published on 10/13/2014
  • Conatus management update

    Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), San Diego, Calif. Business: Inflammation, Infectious, Endocrine/Metabolic Hired: David Hagerty as EVP of clinical development, formerly SVP and CMO of Ardea Biosciences Inc., …

    Published on 10/13/2014
  • CTD Holdings board of directors update

    CTD Holdings Inc. (OTCQB:CTDH), Alachua, Fla. Business: Pharmaceuticals Appointed: N. Scott Fine, a director, as chairman

    Published on 10/13/2014
  • CytRx board of directors update

    CytRx Corp. (NASDAQ:CYTR), Los Angeles, Calif. Business: Cancer Deceased: Max Link, chairman, at the age of 74

    Published on 10/13/2014
  • IntelGenx management update

    IntelGenx Corp. (TSX-V:IGX; OTCQX:IGXT), Saint-Laurent, Quebec Business: Drug delivery Transitioned: Horst Zerbe to president and CEO from interim president and CEO

    Published on 10/13/2014
  • Intellipharmaceutics management update

    Intellipharmaceutics International Inc. (TSX:I; NASDAQ:IPCI), Toronto, Ontario Business: Drug delivery Resigned: Shameze Rampertab as VP of finance and CFO; Amina Odidi, president and former CFO, becomes interim CFO

    Published on 10/13/2014
  • Ipsen management update

    Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Business: Cancer, Endocrine/Metabolic, Neurology Departing: Susheel Surpal as CFO, effective Oct. 31

    Published on 10/13/2014
  • Mast Therapeutics management update

    Mast Therapeutics Inc. (NYSE-M:MSTX), San Diego, Calif. Business: Cardiovascular, Hematology, Cancer Transitioned: Edwin Parsley to CMO and SVP from interim CMO

    Published on 10/13/2014
  • Meda management update

    Meda AB (SSE:MEDAA), Solna, Sweden Business: Pharmaceuticals Resigned: Maria Carell as EVP of North America/Australia and president of Meda's Meda Inc. unit; EVP Ton van't Hullenaar will assume interim country manager …

    Published on 10/13/2014
  • Neurocrine management update

    Neurocrine Biosciences Inc. (NASDAQ:NBIX), San Diego, Calif. Business: Neurology, Cardiovascular, Genitourinary Hired: Malcolm Lloyd-Smith as chief regulatory officer, formerly SVP of regulatory affairs, quality and …

    Published on 10/13/2014
  • NewLink management update

    NewLink Genetics Corp. (NASDAQ:NLNK), Ames, Iowa Business: Cancer Hired: Jack Henneman as EVP and CFO, formerly CFO of Integra LifeSciences Holdings Corp.; he succeeds Gordon Link as CFO

    Published on 10/13/2014
  • Nuvilex board of directors update

    Nuvilex Inc. (OTCQB:NVLX), Silver Spring, Md. Business: Cancer, Gene/Cell therapy Appointed: Kenneth Waggoner, CEO, president and general counsel, as chairman; he succeeds Patricia Gruden, who resigned as chairman and …

    Published on 10/13/2014
  • Nuvilex management update

    Nuvilex Inc. (OTCQB:NVLX), Silver Spring, Md. Business: Cancer, Gene/Cell therapy Hired: Walter Guenzburg as CSO, currently chairman of SG Austria Pte. Ltd.; he succeeds Robert Ryan

    Published on 10/13/2014
  • PlasmaTech Biopharmaceuticals management update

    PlasmaTech Biopharmaceuticals Inc. (OTCBB:ACCP), Dallas, Texas Business: Cancer, Drug delivery Hired: Scott Schorer as CEO; he succeeds Jeffrey Davis who reigned as president, CEO and acting CFO, while remaining a …

    Published on 10/13/2014
  • Vensun Pharmaceuticals management update

    Vensun Pharmaceuticals Inc., Yardley, Pa. Business: Generics Hired: Josh Gordon as SVP of commercial operations, formerly VP and general manager of specialty pharmaceuticals at Hospira Inc.

    Published on 10/13/2014
  • Zynerba management update

    Zynerba Pharmaceuticals Inc., Radnor Pa. Business: Neurology, Autoimmune, Drug delivery Hired: Armando Anido as CEO and chairman, formerly CEO of NuPathe Inc., which Teva Pharmaceutical Industries Ltd acquired; and …

    Published on 10/13/2014
  • ADC Therapeutics management update

    ADC Therapeutics S.a.r.l., Lausanne, Switzerland Business: Cancer Hired: Jay Feingold as CMO and head of oncology clinical development, formerly VP of U.S. medical affairs at Daiichi Sankyo Co. Ltd.

    Published on 10/6/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993